Cowealth Medical Holding Co (ROCO:4745) PEG Ratio: N/A (As of Jul. 13, 2026)


ROCO:4745 Cowealth Medical Holding Co Ltd ROCO:4745
50 GF Score
Price NT$13.80
GF Value NT$13.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Cowealth Medical Holding Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Cowealth Medical Holding Co's PE Ratio without NRI is 0.00. Cowealth Medical Holding Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Cowealth Medical Holding Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Cowealth Medical Holding Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Cowealth Medical Holding Co's highest PEG Ratio was 14.25. The lowest was 0.24. And the median was 2.39.


ROCO:4745's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.93
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Cowealth Medical Holding Co  (ROCO:4745) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Cowealth Medical Holding Co PEG Ratio Related Terms


Cowealth Medical Holding Co PEG Ratio Historical Data

* Premium members only.

The historical data trend for Cowealth Medical Holding Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cowealth Medical Holding Co PEG Ratio Chart

Cowealth Medical Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.91 0.00 0.00 0.00 0.00

Cowealth Medical Holding Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ROCO:4745 vs ABT, SYK, MDT: PEG Ratio Comparison

For the Medical Devices subindustry, Cowealth Medical Holding Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cowealth Medical Holding Co PEG Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Cowealth Medical Holding Co's PEG Ratio falls into.


ROCO:4745
50GF Score
Cowealth Medical Holding Co Ltd ROCO:4745
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cowealth Medical Holding Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Cowealth Medical Holding Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.

Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?

Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued. The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11. GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.

Key valuation signals for ROCO:4745:

  • PEG Ratio: N/A
  • GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cowealth Medical Holding Co Business Description

Address North Sound Road, Suite 102, Cannon Place, P.O. Box 712, George Town, Grand Cayman, CYM, KY1-9006
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score

Get the complete analysis for ROCO:4745

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.80
Price
NT$13.11
GF Value